DMB Acquisition Corp.

General Information

(Note: DMB Acquisition Corp. withdrew its SPAC IPO in an SEC filing dated Sept. 22, 2022. This blank check company’s IPO had been in the works since July 2021. Unlike most SPAC IPOs, this deal was planned as a stock-only offering – no warrants.)

We intend to focus on businesses that have their primary operations located in North America in the healthcare industry. (Incorporated in Delaware)

LifeSci Holdings LLC, an entity affiliated with LifeSci Capital LLC, a research-driven investment bank with deep domain expertise in the life sciences.

It is our intention to pursue prospective targets that are focused on healthcare innovation. We anticipate targeting companies domiciled in North America or Europe that are developing assets in the biopharma, medical technology, digital health and healthcare services sectors, which aligns with our management team’s experience in healthcare investing and drug development. 



Employees: 0
Founded: 2019
Contact Information
Address 250 W 55th St #3401, New York, NY 10019
Phone Number (646) 889-1200
Web Address
View Prospectus: DMB Acquisition Corp.
Financial Information
Market Cap $93.75mil
Revenues $0 mil (last 12 months)
Net Income $0 mil (last 12 months)
IPO Profile
Symbol LSAC
Exchange NASDAQ
Shares (millions): 7.5
Price range $10.00 - $10.00
Est. $ Volume $75.0 mil
Manager / Joint Managers LifeSci Capital/ Ladenburg Thalmann
Expected To Trade:
Status: Withdrawn
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change